MedTrace Logo

Comparison of Clinical Performance of Supraglottic Airway Devices

NCT06850675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-02-27

No results posted yet for this study

Summary

Abstract

Aim: To compare the clinical performance and pharyngolaryngeal complications of two second-generation, supraglottic airway devices (SGAD), the I-gel and Laryngeal Mask Airway-Supreme (LMA-Supreme), in geriatric patients undergoing elective surgery under general anesthesia.

Materials and Methods: After hospital ethics committee approval (19-4.1T/40- 17.04.2019) and written informed consent, patients aged 65 years and older, with an American Society of Anesthesiologists score of I-III, and who were scheduled for elective urological surgery under general anesthesia, were included prospectively. The patients were randomly divided into two equal sized groups, I-gel and LMA-supreme. The two groups were evaluated and compared for ease of supraglottic airway device insertion, time of insertion, success rate at first insertion, number of attempts, ease of gastric tube insertion, oropharyngeal leak pressure, and intraoperative and postoperative complications.

Conditions

  • Supraglottic Airway Devices
  • Geriatric Patient

Interventions

OTHER

Clinical performance

Supraglottic airway devices were evaluated for ease of insertion, time of insertion, success rate at first attempt, number of attempts, ease of gastric tube insertion, oropharyngeal leak pressure, and intraoperative and postoperative complications

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • NURSEN KARACA, MEDİCAL DOCTOR · Ege University Medical Faculty, Department of Anesthesiology and Reanimation

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-17
Primary Completion
2020-04-17
Completion
2020-05-17

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06850675 on ClinicalTrials.gov